Страна: Австралия
Язык: английский
Источник: Department of Health (Therapeutic Goods Administration)
sumatriptan succinate, Quantity: 140 mg
Arrotex Pharmaceuticals Pty Ltd
sumatriptan succinate
Tablet
Excipient Ingredients: microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; lactose; crospovidone; magnesium stearate; titanium dioxide; hypromellose; macrogol 400
Oral
2 tablets
(S4) Prescription Only Medicine
Sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. There is no information available on the use of sumatriptan tablets in the treatment of basilar or hemiplegic migraine.
Visual Identification: White coloured, capsule shaped, biconvex film-coated tablets debossed with"100" one side and plain on the other side which contain Sumatriptan (as succinate) 100 mg.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2010-06-18
1 AUSTRALIAN PRODUCT INFORMATION –CHEMMART SUMATRIPTAN, (SUMATRIPTAN SUCCINATE) TABLETS 1 NAME OF THE MEDICINE Sumatriptan succinate. 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM Each tablet contains 50 mg sumatriptan (as succinate), as the active ingredient. In addition, each tablet contains the following inactive ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and Opadry 03B84755 Pink (50 mg) or Opadry 03B28796 White (100 mg) as coating material. The coating material contains hypromellose, titanium dioxide, polyethylene glycol, iron oxide red (50 mg only) and iron oxide black (50 mg only). Chemmart Sumatriptan tablets are intended for oral administration. Each tablet contains 50 mg or 100 mg sumatriptan (as succinate), as the active ingredient. 50 mg Tablets: Pink coloured, capsule shaped, biconvex film coated tablets, debossed with “50” on one side and plain on the other side. 100 mg Tablets: White coloured, capsule shaped, biconvex film coated tablets debossed with “100” on one side and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sumatriptan tablets are indicated for the acute relief of migraine attacks with or without aura. There is no information available on the use of Sumatriptan tablets in the treatment of basilar or hemiplegic migraine. 4.2 DOSE AND METHOD OF ADMINISTRATION Sumatriptan is indicated for the acute intermittent relief of both migraine and cluster headache. It should not be used prophylactically. Ergotamine or ergotamine derivatives and sumatriptan should not be administered concurrently (see SECTION 4.3 - CONTRAINDICATIONS). MIGRAINE It is recommended to start the treatment at the first sign of a migraine headache or associated symptoms such as nausea, vomiting or photophobia. The efficacy of sumatriptan is 2 independent of the duration of the attack when starting treatment. Administration during a migraine aura prior to oth Прочитать полный документ